Effects of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor, on Slowly Expanding Lesions: An Emerging Imaging Marker of Chronic Tissue Loss in Multiple Sclerosis (S14.009)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor, on Slowly Expanding Lesions: An Emerging Imaging Marker of Chronic Tissue Loss in Multiple Sclerosis (S14.009)

Published:2022-05-03 Issue:18_supplement Volume:98 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Arnold Douglas¹,Elliott Colm¹,Montalban Xavier²,Martin Emily³,Hyvert Yann⁴,Tomic Davorka⁵

Affiliation:

1. NeuroRx Research

2. Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron

3. EMD Serono

4. The healthcare business of Merck KGaA

5. Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair;Acta Neuropathologica;2024-04-24

2. Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis;Neurologic Clinics;2024-02

3. Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment;Neurologic Clinics;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP